Glaxo cuts price of HIV drugs for world's poorest countries

Article Abstract:

UK pharmaceutical firm GlaxoSmithKline PLC reduced prices on its anti-HIV agents to developing nations, the company's fifth such discount since 1997. The across-the-board discount for these therapeutics averages 21%, with the largest discount on Ziagen, at nearly 40%.

Commodity & service prices, Public affairs, Global Marketing, United Kingdom, Economic aspects, Prices and rates, Public relations, Corporate social responsibility, Antiviral agents, Company public relations, Anti-HIV agents, GlaxoSmithKline PLC, Company pricing policy, International marketing

---

Pfizer may double outsourcing

Article Abstract:

US-based Pfizer Inc. is planning to outsource nearly a third of its manufacturing, focusing on Asia. The move is part of a cost-reduction strategy. The pharmaceuticals firm currently outsources approximately 15% of its manufacturing processes.

Use of services, Asia, Outsourcing

---

Pfizer tries to sell research spending

Article Abstract:

Pfizer Inc. of the United States is to hold a meeting to convince investors that the billions of dollars spent on pharmaceutical research will produce. The meeting is an update on its drug pipeline.

Financial management, Marketing, Company marketing practices, Investor relations, Company overview

Similar abstracts:

• Abstracts: Secrets to on-the-go grooming. Bliss secrets from the world's happiest women
• Abstracts: A condition based maintenance model for a two-unit series system. Optimal preventive maintenance of a production system with an intermediate buffer
• Abstracts: Pulling the strings of China's Internet. Japan emerges from its trade shell. Towards financial efficiency
• Abstracts: Belgian utilities create company for Nordic area. Road test; as VW cranks out more models, they start to look alike

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.